We hypothesized a possible correlation between elevated serum OPG levels in patients with CKD stages 3–5 and markers of presence and severity of CVD, and investigated whether OPG is a possible independent marker of cardiovascular mortality in patients with CKD over a 5-year follow-up period. The gene discussed is TNFRSF11B; the disease is chronic kidney disease.